4D Pharma PLC Warrant
LBPSW
LBPSW was delisted on the 29th of June, 2022.
6 hedge funds and large institutions have $315K invested in 4D Pharma PLC Warrant in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.
20% more funds holding
Funds holding: 5 → 6 (+1)
38% less capital invested
Capital invested by funds: $506K → $315K (-$191K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$11.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$11.4K |
| 2 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$2.51K |
LBPSW Hedge Fund Activity: Q3 2021 in Review
6 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in 4D Pharma PLC Warrant (LBPSW) for Q3 2021, worth a combined $315K — down 38% from $506K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new LBPSW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $11.2K. The largest seller was AQR Arbitrage, cutting an estimated $11.4K.
- 6 institutional investors held 4D Pharma PLC Warrant (LBPSW) as of Q3 2021, up from 5 in Q2 2021.
- Funds reported $315K of 4D Pharma PLC Warrant stock for Q3 2021, down 38% quarter-over-quarter.
- 1 fund opened new 4D Pharma PLC Warrant positions in Q3 2021 and 0 closed out, a net change of +1 holder.
- The largest 4D Pharma PLC Warrant buyer in Q3 2021 was Susquehanna International Group, an estimated $11.2K added.
- The largest 4D Pharma PLC Warrant seller in Q3 2021 was AQR Arbitrage, an estimated $11.4K sold.
Based on aggregated 13F filings for Q3 2021.